跳至主要内容
临床试验/NCT06093594
NCT06093594尚未招募不适用

Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Rate of stage IV melanoma patients who remain in clinical trial to trial completion

研究概览

简要总结

Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years old
  • Diagnosis of stage IV melanoma
  • Able to comprehend the investigational nature of the protocol and provide informed consent

排除标准

  • Female patients who are currently pregnant or nursing
  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
  • Inability to perform regular electronic reporting

结局指标

主要结局

Rate of stage IV melanoma patients who remain in clinical trial to trial completion

时间窗: 12 months

Number of stage IV melanoma patients who decide to enroll in a clinical research

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验